Abstract
Homeostasis of most tissues and organs is maintained by tissue-specific somatic or adult stem cells (SCs) and their early progenitors possessing two main properties: self-renewal and differentiation. To fulfil these two functions, they must undergo either symmetrical division for stem cell expansion, necessary after injury for example, or asymmetrical division for stem cell maintenance and progenitor production. The “cancer stem cell hypothesis” postulates that tumours arise from adult stem cells called cancer stem cells (CSCs) that possess stem cell properties. There is growing evidence that most solid tumours and haematological malignancies are driven by CSCs as a result of advances in stem cell biology and the development of animal models. This has fundamental implications for understanding the biology of cancers and also for developing new therapeutic strategies. The recent characterisation of CSC in head and neck squamous cell carcinoma (HNSCC) prompted us to re-examine the disease development and to discuss the limited effects of conventional therapies.
Keywords: Stem cell, cancer stem cell, p63, head and neck squamous cell carcinoma, oral epithelium
Current Cancer Therapy Reviews
Title: Cancer Stem Cells of Head and Neck Squamous Cell Carcinoma
Volume: 5 Issue: 2
Author(s): Mathilde Lechevrel and Brigitte Sola
Affiliation:
Keywords: Stem cell, cancer stem cell, p63, head and neck squamous cell carcinoma, oral epithelium
Abstract: Homeostasis of most tissues and organs is maintained by tissue-specific somatic or adult stem cells (SCs) and their early progenitors possessing two main properties: self-renewal and differentiation. To fulfil these two functions, they must undergo either symmetrical division for stem cell expansion, necessary after injury for example, or asymmetrical division for stem cell maintenance and progenitor production. The “cancer stem cell hypothesis” postulates that tumours arise from adult stem cells called cancer stem cells (CSCs) that possess stem cell properties. There is growing evidence that most solid tumours and haematological malignancies are driven by CSCs as a result of advances in stem cell biology and the development of animal models. This has fundamental implications for understanding the biology of cancers and also for developing new therapeutic strategies. The recent characterisation of CSC in head and neck squamous cell carcinoma (HNSCC) prompted us to re-examine the disease development and to discuss the limited effects of conventional therapies.
Export Options
About this article
Cite this article as:
Lechevrel Mathilde and Sola Brigitte, Cancer Stem Cells of Head and Neck Squamous Cell Carcinoma, Current Cancer Therapy Reviews 2009; 5(2) . https://dx.doi.org/10.2174/157339409788166797
DOI https://dx.doi.org/10.2174/157339409788166797 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Extracellular Matrix and Aberrant Signaling in Lung Carcinoma: Role of Fibronectin in the Control of Human Lung Carcinoma Cell Growth,Apoptosis and Resistance to Therapy
Current Signal Transduction Therapy Dasatinib: An Anti-Tumour Agent via Src Inhibition
Current Drug Targets Cancer-Targeting Multifunctionalized Gold Nanoparticles in Imaging and Therapy
Current Medicinal Chemistry Suicide Gene Therapy Against Malignant Gliomas by the Local Delivery of Genetically Engineered Umbilical Cord Mesenchymal Stem Cells as Cellular Vehicles
Current Gene Therapy Oncolytic HSV-1 Virotherapy: Clinical Experience and Opportunities for Progress
Current Pharmaceutical Biotechnology Bone Invasive Properties of Oral Squamous Cell Carcinoma and its Interactions with Alveolar Bone Cells: An In Vitro Study
Current Cancer Drug Targets Calcium and Vitamin D Signaling in the Epidermal Response to Wounding
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Genomic Targets in Inflammation and in Allergic Reactions: A Patientoriented Approach
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Novel Antibody Therapeutics Targeting Mesothelin In Solid Tumors
Clinical Cancer Drugs New Agents – Manifold Consequences: The Management of Lung and Colorectal Cancer is Changing
Current Cancer Therapy Reviews Targeting the Hippo Pathway for Anti-cancer Therapies
Current Medicinal Chemistry Melatonin and Respiratory Diseases: A Review
Current Topics in Medicinal Chemistry <sup>90</sup>Y-DOTA-Nimotuzumab: Synthesis of a Promising β− Radiopharmaceutical
Current Radiopharmaceuticals Tapasin and Human Leukocyte Antigen Class I Dysregulation Correlates with Survival in Glioblastoma Multiforme
Anti-Cancer Agents in Medicinal Chemistry Targeting Microtubules to Inhibit Angiogenesis and Disrupt Tumour Vasculature:Implications for Cancer Treatment
Current Cancer Drug Targets Advances in the Physiology of GPR55 in the Central Nervous System
Current Neuropharmacology Ferulic Acid Activity in Topical Formulations: Technological and Scientific Prospecting
Current Pharmaceutical Design PPARγ and Its Ligands: Potential Antitumor Agents in the Digestive System
Current Stem Cell Research & Therapy Identification of KEY lncRNAs and mRNAs Associated with Oral Squamous Cell Carcinoma Progression
Current Bioinformatics Integrins in Drug Targeting-RGD Templates in Toxins
Current Pharmaceutical Design